Skip to main content

Smith Hunter C

Chief Financial Officer | CFO And Interim CEO

1 company

Insider Signal Score

38
Weak
Trades Analyzed
25
12M Win Rate
0.0%
Avg 3M Return
-4.0%
Avg 12M Return
-61.6%

Smith Hunter C is a Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 33 sells.

Estimated insider holdings value: $12.3M based on current market prices.

Holdings by Company

RYTMFeb 19, 2026
Current Shares111.1K
Value$12.30M
Net Activity-194,102
Bought: 0Sold: 194.1K

Transaction History

Showing 10 filings
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Feb 19, 2026
RYTM
Rhythm Pharmaceuticals, Inc.
Chief Financial OfficerSell7,954$101.31$805,813.76-0.8%-12.1%-
Feb 12, 2026
RYTM
Rhythm Pharmaceuticals, Inc.
Chief Financial OfficerSell7,071$100.21$708,575.59-0.6%-2.4%-
Aug 13, 2025
RYTM
Rhythm Pharmaceuticals, Inc.
Chief Financial OfficerSale+OE28,088$96.29$2,704,623.77-10.7%+2.0%-
Jul 9, 2025
RYTM
Rhythm Pharmaceuticals, Inc.
Chief Financial OfficerSale+OE42,120$80.48$3,389,756.13-9.5%+12.2%+29.8%
May 30, 2025
RYTM
Rhythm Pharmaceuticals, Inc.
Chief Financial OfficerSale+OE23,400$61.41$1,437,010.37-8.9%+69.9%+44.0%
Feb 19, 2025
RYTM
Rhythm Pharmaceuticals, Inc.
Chief Financial OfficerSale+OE2,215$57.22$126,742.30-2.0%+10.1%+77.9%
Feb 12, 2025
RYTM
Rhythm Pharmaceuticals, Inc.
Chief Financial OfficerSell751$56.39$42,346.85-0.4%-1.5%+66.7%
Feb 11, 2025
RYTM
Rhythm Pharmaceuticals, Inc.
Chief Financial OfficerSale+OE1,296$57.51$74,533.06-0.6%+2.4%+71.0%
Feb 4, 2025
RYTM
Rhythm Pharmaceuticals, Inc.
Chief Financial OfficerSale+OE1,678$59.43$99,723.54-1.6%+7.4%+80.1%
Mar 19, 2024
RYTM
Rhythm Pharmaceuticals, Inc.
Chief Financial OfficerSell15,515$39.22$608,498.30-13.7%+5.2%+41.1%
Page 1Next →